KATHRYN ALLEN: Open Payments
NPI 1346390820 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 28 payments from 16 companies in 2025. Trend: 2023 $596 · 2024 $612 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| ABBVIE INC. | 2 | $48 |
| Eisai Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $19 |
| Insulet Corporation | 1 | $19 |
Products named: MOUNJARO, XIFAXAN, VRAYLAR, Leqembi, FANAPT, Wegovy, ZURZUVAE, Ozempic.
Industry payments across KY — which companies pay providers there.
